Antibody-Drug Conjugates Used in Breast Cancers

The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publicatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbas, Aram J., Ibrahim, Marah F., Saifo, Maher S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257388/
https://www.ncbi.nlm.nih.gov/pubmed/34257655
http://dx.doi.org/10.1155/2021/9927433
_version_ 1783718303021137920
author Abbas, Aram J.
Ibrahim, Marah F.
Saifo, Maher S.
author_facet Abbas, Aram J.
Ibrahim, Marah F.
Saifo, Maher S.
author_sort Abbas, Aram J.
collection PubMed
description The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer.
format Online
Article
Text
id pubmed-8257388
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-82573882021-07-12 Antibody-Drug Conjugates Used in Breast Cancers Abbas, Aram J. Ibrahim, Marah F. Saifo, Maher S. J Oncol Review Article The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer. Hindawi 2021-06-28 /pmc/articles/PMC8257388/ /pubmed/34257655 http://dx.doi.org/10.1155/2021/9927433 Text en Copyright © 2021 Aram J. Abbas et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Abbas, Aram J.
Ibrahim, Marah F.
Saifo, Maher S.
Antibody-Drug Conjugates Used in Breast Cancers
title Antibody-Drug Conjugates Used in Breast Cancers
title_full Antibody-Drug Conjugates Used in Breast Cancers
title_fullStr Antibody-Drug Conjugates Used in Breast Cancers
title_full_unstemmed Antibody-Drug Conjugates Used in Breast Cancers
title_short Antibody-Drug Conjugates Used in Breast Cancers
title_sort antibody-drug conjugates used in breast cancers
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257388/
https://www.ncbi.nlm.nih.gov/pubmed/34257655
http://dx.doi.org/10.1155/2021/9927433
work_keys_str_mv AT abbasaramj antibodydrugconjugatesusedinbreastcancers
AT ibrahimmarahf antibodydrugconjugatesusedinbreastcancers
AT saifomahers antibodydrugconjugatesusedinbreastcancers

Ejemplares similares